Source: Eur Respir J 2016; 48: 1240-1242



Rating:

Share or cite this content

Citations should be made in the following way:
Gomez Diana C., Mehrad Borna. Eosinophilic pneumonia associated with pirfenidone therapy. Eur Respir J 2016; 48: 1240-1242

Member's Comments

No comment yet.

Related content which might interest you: Meloxicam associated eosinophilic pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 218s Year: 2001 Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia Source: Eur Respir J 2015; 45: 1624-1631 Year: 2015 Cryptogenic organizing pneumonia – Results of treatment with clarithromycin versus corticosteroids Source: International Congress 2016 – Orphan diseases II Year: 2016 Eosinophilic pneumonias Source: Eur Respir Monogr 2022; 95: 141-152 Year: 2022 Eosinophilic refractory inflammation in OCS-dependent severe asthma Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Eosinophilic COPD Source: Eur Respir Monogr 2022; 95: 100-118 Year: 2022 A 12-week combination of clarithromycin and prednisone for the treatment of cryptogenic and radiation-induced organising pneumonia Source: International Congress 2015 – New insights into IIPs Year: 2015 Recurrent eosinophilic pneumonia in an asthmatic patient treated with sequential montelukast/zafirlukast after corticosteroid withdrawal Source: Eur Respir J 2002; 20: Suppl. 38, 52s Year: 2002 Azithromycin in treatment of atypical pneumonia in children Source: Eur Respir J 2004; 24: Suppl. 48, 716s Year: 2004 Clinical implication of interleukin-33 in acute eosinophilic pneumonia compared with chronic eosinophilic pneumonia Source: Annual Congress 2011 - Biomarkers of allergic inflammation Year: 2011 Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia Source: Eur Respir J 2005; 25: 528-533 Year: 2005 Eosinophilic asthma Source: Eur Respir Monogr 2022; 95: 73-99 Year: 2022 Treatment of exacerbations of fibrotic idiopathic interstitial pneumonias with cyclophosphamide and corticosteroids Source: Annual Congress 2010 - New insights in the treatment of idiopathic pulmonary fibrosis Year: 2010 Effect of pirfenidone on chronic interstitial pneumonia Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Manifestation of idiopathic chronic eosinophilic pneumonia Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Systemic corticosteroid for treating severe community-acquired pneumonia Source: International Congress 2015 – Advances in pneumonia management, COPD therapy and lung nodule evaluation Year: 2015 Fibrosing cases of chronic eosinophilic pneumonia Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 Cyclosporine A in the treatment of idiopathic pulmonary fibrosis/usual interstitial pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 62s Year: 2002 Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 Simvastatin in the treatment of eosinophilic asthma Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010